326 related articles for article (PubMed ID: 26432848)
1. Survival in synucleinopathies: A prospective cohort study.
Goldstein DS; Holmes C; Sharabi Y; Wu T
Neurology; 2015 Nov; 85(18):1554-61. PubMed ID: 26432848
[TBL] [Abstract][Full Text] [Related]
2. Long-term trends in myocardial sympathetic innervation and function in synucleinopathies.
Lamotte G; Holmes C; Wu T; Goldstein DS
Parkinsonism Relat Disord; 2019 Oct; 67():27-33. PubMed ID: 31621602
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
[TBL] [Abstract][Full Text] [Related]
4. Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies.
Lamotte G; Holmes C; Sullivan P; Lenka A; Goldstein DS
Ann Clin Transl Neurol; 2020 Dec; 7(12):2450-2460. PubMed ID: 33216462
[TBL] [Abstract][Full Text] [Related]
5. Neuropharmacologic distinction of neurogenic orthostatic hypotension syndromes.
Sharabi Y; Eldadah B; Li ST; Dendi R; Pechnik S; Holmes C; Goldstein DS
Clin Neuropharmacol; 2006; 29(3):97-105. PubMed ID: 16772807
[TBL] [Abstract][Full Text] [Related]
6. Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.
Gibbons CH; Levine T; Adler C; Bellaire B; Wang N; Stohl J; Agarwal P; Aldridge GM; Barboi A; Evidente VGH; Galasko D; Geschwind MD; Gonzalez-Duarte A; Gil R; Gudesblatt M; Isaacson SH; Kaufmann H; Khemani P; Kumar R; Lamotte G; Liu AJ; McFarland NR; Miglis M; Reynolds A; Sahagian GA; Saint-Hillaire MH; Schwartzbard JB; Singer W; Soileau MJ; Vernino S; Yerstein O; Freeman R
JAMA; 2024 Apr; 331(15):1298-1306. PubMed ID: 38506839
[TBL] [Abstract][Full Text] [Related]
7. Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.
Goldstein DS; Sullivan P; Holmes C; Lamotte G; Lenka A; Sharabi Y
J Neurochem; 2021 Jul; 158(2):554-568. PubMed ID: 33894018
[TBL] [Abstract][Full Text] [Related]
8. Pure autonomic failure.
Garland EM; Hooper WB; Robertson D
Handb Clin Neurol; 2013; 117():243-57. PubMed ID: 24095130
[TBL] [Abstract][Full Text] [Related]
9. Olfactory dysfunction in pure autonomic failure: Implications for the pathogenesis of Lewy body diseases.
Goldstein DS; Sewell L
Parkinsonism Relat Disord; 2009 Aug; 15(7):516-20. PubMed ID: 19201246
[TBL] [Abstract][Full Text] [Related]
10. Natural history of multiple system atrophy in the USA: a prospective cohort study.
Low PA; Reich SG; Jankovic J; Shults CW; Stern MB; Novak P; Tanner CM; Gilman S; Marshall FJ; Wooten F; Racette B; Chelimsky T; Singer W; Sletten DM; Sandroni P; Mandrekar J
Lancet Neurol; 2015 Jul; 14(7):710-9. PubMed ID: 26025783
[TBL] [Abstract][Full Text] [Related]
11. Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.
Goldstein DS; Isonaka R; Lamotte G; Kaufmann H
Clin Auton Res; 2021 Dec; 31(6):677-684. PubMed ID: 34669076
[TBL] [Abstract][Full Text] [Related]
12. Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension.
Donadio V; Incensi A; Rizzo G; De Micco R; Tessitore A; Devigili G; Del Sorbo F; Bonvegna S; Infante R; Magnani M; Zenesini C; Vignatelli L; Cilia R; Eleopra R; Tedeschi G; Liguori R
Mov Disord; 2020 Sep; 35(9):1649-1657. PubMed ID: 32557839
[TBL] [Abstract][Full Text] [Related]
13. Hyposmia in pure autonomic failure.
Silveira-Moriyama L; Mathias C; Mason L; Best C; Quinn NP; Lees AJ
Neurology; 2009 May; 72(19):1677-81. PubMed ID: 19433741
[TBL] [Abstract][Full Text] [Related]
14. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
15. Association Between Orthostatic Hypotension and Dementia in Patients With Parkinson Disease and Multiple System Atrophy.
Ruiz Barrio I; Miki Y; Jaunmuktane ZT; Warner T; De Pablo-Fernandez E
Neurology; 2023 Mar; 100(10):e998-e1008. PubMed ID: 36526431
[TBL] [Abstract][Full Text] [Related]
16. Cardiac and extracardiac sympathetic denervation in Parkinson's disease with orthostatic hypotension and in pure autonomic failure.
Tipre DN; Goldstein DS
J Nucl Med; 2005 Nov; 46(11):1775-81. PubMed ID: 16269589
[TBL] [Abstract][Full Text] [Related]
17. The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.
Leys F; Wenning GK; Fanciulli A
Neurol Sci; 2022 Jan; 43(1):187-198. PubMed ID: 34817726
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular responses during cold pressor test are different in Parkinson disease and multiple system atrophy with parkinsonism.
Roy S; Srivastava AK; Jaryal AK; Deepak KK
Clin Auton Res; 2015 Aug; 25(4):219-24. PubMed ID: 26220575
[TBL] [Abstract][Full Text] [Related]
19. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
[TBL] [Abstract][Full Text] [Related]
20. An overview on pure autonomic failure.
Pavy-Le Traon A; Foubert-Samier A; Fabbri M
Rev Neurol (Paris); 2024; 180(1-2):94-100. PubMed ID: 38129276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
